Creating a “Transcampus” in Diabetes Research Between King’s College London and the Technische Universität Dresden: Update on Islet Biology and Transplantation

Nutritional supplements and herbal medicines for women with polycystic ovary syndrome; a systematic review and meta-analysis

“…The sample sizes ranged from 10 [ 43 ] to 283 [ 37 ]. All studies were conducted at university hospitals or clinical research centres in America [ 42 , 43 , 46 , 51 , 52 ], Australia [ 35 ], Egypt [ 49 ], Hong Kong [ 33 ], Iran [ 32 , 40 , 44 , 47 , 48 , 50 , 54 ], Italy [ 31 , 34 , 36 – 38 ], Turkey [ 53 ], United Kingdom [ 39 ] and Venezuela [ 41 , 45 ].…”

“…One study stratified randomization according to BMI (overweight or normal weight) [ 47 ]. Seventeen studies excluded participants with other endocrine disease [ 42 , 46 , 53 , 54 ] and elevated serum prolactin (PRL) [ 31 – 33 , 35 , 37 , 38 , 41 , 44 , 46 – 48 , 50 – 52 ].…”

“… 12 weeks Cimicifuga racemosa Shahin AY; Mohammed SA. 2014 [ 48 ] 120 mg Cimicifuga extract plus clomiphene 150 mg on menstrual cycle days 3–7, trigger injection (10,000 IU, intramuscular Human Chorionic Gonadotropin) and progesterone supplementation (50mcg per day for two days following trigger injection) (Klimadynon® Bionorica, Neumarkt, Germany) (Pregnyl, Organon, Holland, The Netherlands) Clomiphene, 150 mg per day administered on menstrual cycle days three to seven, a trigger injection (HCG) and progesterone support (50mcg per day for two days following trigger injection). (Pregnyl, Organon, Holland, The Netherlands) Three alternate menstrual cycles Cinnamomum sp.…”

“…Fourteen trials reported on the outcomes of biochemical hyperandrogenism [ 31 , 33 – 36 , 39 – 43 , 45 , 48 , 51 , 54 ]. Four trials reported on the outcomes of clinical hyperandrogenism with validated tools including the modified Ferriman Gallwey score to measure degree of hirsutism [ 39 , 48 , 50 , 54 ], and acne with the dermatology quality of life index for health related quality of life [ 39 ]. Eight trials reported anthropometric outcomes of participants [ 33 , 37 , 38 , 44 , 50 , 52 – 54 ].…”

“…Three studies did not report the effect of high attrition (over 30%) on baseline menstrual characteristics in the test and control groups [ 37 , 38 , 42 ]. Twelve studies declared conflicts of interest [ 31 , 32 , 35 , 36 , 42 , 44 – 46 , 48 , 49 , 51 , 54 ]. Ten studies reported no conflicts of interest and two studies reported potential conflicts of interest due to authors’ affiliations [46; 45].…”